These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7011656)

  • 1. Acetylator phenotype and lupus erythematosus.
    Uetrecht JP; Woosley RL
    Clin Pharmacokinet; 1981; 6(2):118-34. PubMed ID: 7011656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatic amines and the pathogenesis of lupus erythematosus.
    Reidenberg MM
    Am J Med; 1983 Dec; 75(6):1037-42. PubMed ID: 6196968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical consequences of polymorphic acetylation of basic drugs.
    Drayer DE; Reidenberg MM
    Clin Pharmacol Ther; 1977 Sep; 22(3):251-8. PubMed ID: 19187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.
    Batchelor JR; Welsh KI; Tinoco RM; Dollery CT; Hughes GR; Bernstein R; Ryan P; Naish PF; Aber GM; Bing RF; Russell GI
    Lancet; 1980 May; 1(8178):1107-9. PubMed ID: 6103441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA
    N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide.
    Sonnhag C; Karlsson E; Hed J
    Acta Med Scand; 1979; 206(4):245-51. PubMed ID: 92167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype.
    Russell GI; Bing RF; Jones JA; Thurston H; Swales JD
    Q J Med; 1987 Oct; 65(246):845-52. PubMed ID: 3329739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.
    Strandberg I; Boman G; Hassler L; Sjöqvist F
    Acta Med Scand; 1976; 200(5):367-71. PubMed ID: 983808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug acetylation and expression of lupus erythematosus.
    Marsden JR; Mason GG; Coburn PR; Rawlins MD; Shuster S
    Eur J Clin Pharmacol; 1985; 28(4):387-90. PubMed ID: 4029245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal distribution of acetylation phenotypes in systemic lupus erythematosus.
    Vansant J; Woosley RL; John JT; Sergent JS
    Arthritis Rheum; 1978 Mar; 21(2):192-5. PubMed ID: 637885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced systemic lupus erythematosus.
    Stratton MA
    Clin Pharm; 1985; 4(6):657-63. PubMed ID: 2866863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced systemic lupus erythematosus.
    Weinstein A
    Prog Clin Immunol; 1980; 4():1-21. PubMed ID: 6992215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced autoimmune disease.
    Tan EM
    Fed Proc; 1974 Aug; 33(8):1894-7. PubMed ID: 4135739
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic studies on the drug-related lupus syndrome. Differences in antinuclear antibody development and drug-induced DNA damage in rapid and slow acetylator animal models.
    Weber WW; Tannen RH
    Arthritis Rheum; 1981 Aug; 24(8):979-86. PubMed ID: 6974557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between slow acetylator status and spontaneous lupus erythematosus.
    Kumana CR; Chan MM; Wong KL; Wong RW; Kou M; Lauder IJ
    Clin Pharmacol Ther; 1990 Aug; 48(2):208-13. PubMed ID: 2379389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear antibodies related to acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):485-90. PubMed ID: 6970809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced systemic lupus erythematosus.
    JAMA; 1969 Apr; 208(3):525-6. PubMed ID: 5818532
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydrallazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype.
    Harland SJ; Facchini V; Timbrell JA
    Br Med J; 1980 Jul; 281(6235):273-4. PubMed ID: 7427242
    [No Abstract]   [Full Text] [Related]  

  • 20. The chemical induction of systemic lupus erythematosus and lupus-like illnesses.
    Reidenberg MM
    Arthritis Rheum; 1981 Aug; 24(8):1004-9. PubMed ID: 6169347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.